Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Christopher Hallock

Physician Assistant Marietta, GA Physician Assistant

NPI 1518552405 CMS profile 10854014

4994 Lower Roswell Rd Ste 5, Marietta, GA 30068

Open in the dashboard

General payments

$4,625

263 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Christopher Hallock of Marietta, GA is reported in the CMS Open Payments database as having received $4,625 across 263 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,142 58
2024 General $1,611 86
2023 General $1,127 76
2022 General $453 26
2021 General $291 17

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Hallock
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Christopher Hallock were reported at $1,142. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Christopher Hallock Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $291 $132 $37–$438 $132
2022 $453 $155 $48–$522 $149
2023 $1,127 $167 $52–$557 $160
2024 $1,611 $178 $55–$600 $164
2025 $1,142 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $770 45 payments
  2. Supernus Pharmaceuticals, Inc. $643 34 payments
  3. Lundbeck LLC $325 15 payments
  4. ITI, Inc. $315 17 payments
  5. Ironshore Pharmaceuticals Inc. $311 20 payments
  6. Tris Pharma Inc $269 15 payments
  7. Otsuka America Pharmaceutical, Inc. $266 16 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $257 15 payments
  9. Axsome Therapeutics, Inc. $245 13 payments
  10. Neos Therapeutics, LP $219 18 payments
  11. Other $1,004 55 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,625 263 payments
Products named General payments · program years 2021–2025
  1. VRAYLAR $675 40 payments
  2. Qelbree $489 23 payments
  3. REXULTI Psychiatry $307 14 payments
  4. CAPLYTA $276 15 payments
  5. TRINTELLIX $245 14 payments
  6. Auvelity $245 13 payments
  7. REXULTI Psychiatry $229 14 payments
  8. Dyanavel XR $214 12 payments
  9. JORNAY PM $208 14 payments
  10. Adzenys XR-ODT $199 17 payments
  11. Other $2,126 119 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

263 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record